Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 26 citing articles:

Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
Despoina Chrysostomou, Lauren A. Roberts, Julian R. Marchesi, et al.
Gastroenterology (2022) Vol. 164, Iss. 2, pp. 198-213
Open Access | Times Cited: 141
Intermittent fasting interventions to leverage metabolic and circadian mechanisms for cancer treatment and supportive care outcomes
Faiza Kalam, Dara James, Leslie A. Lange, et al.
JNCI Monographs (2023) Vol. 2023, Iss. 61, pp. 84-103
Open Access | Times Cited: 26
Dietary Interventions in Cancer Treatment and Response: A Comprehensive Review
Benjamin Mercier, Eemon Tizpa, Errol J. Philip, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5149-5149
Open Access | Times Cited: 28
Intermittent fasting and immunomodulatory effects: A systematic review
Zhangyuting He, Haifeng Xu, Changcan Li, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 11
The oncobiome; what, so what, now what?
Munawar Abbas, Mark Tangney
Microbiome Research Reports (2025) Vol. 4, Iss. 1
Open Access
Applications of Machine Learning in Chronic Myeloid Leukemia
Mohamed Elhadary, Ahmed Elsabagh, Khaled Ferih, et al.
Diagnostics (2023) Vol. 13, Iss. 7, pp. 1330-1330
Open Access | Times Cited: 8
Clinicopathological Variables and Outcome in Chronic Myeloid Leukemia Associated With BCR-ABL1 Transcript Type and Body Weight: An Outcome of European LeukemiaNet Project
Mohammad Abdul-Jaber Abdulla, Prem Chandra, Susanna Akiki, et al.
Cancer Control (2021) Vol. 28
Open Access | Times Cited: 17
The role of intermittent fasting and the ketogenic diet in cancer disease: can they replace the Mediterranean diet?
Aleyna Nur Küçük, Seda Çiftçi
European Journal of Cancer Prevention (2023) Vol. 32, Iss. 6, pp. 533-543
Closed Access | Times Cited: 7
The Safety of Novel Therapies in Chronic Lymphocytic Leukemia in the Era of Intermittent Fasting: A Pharmacology-Based Review
Maria Benkhadra, N. Fituri, Soha Aboukhalaf, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2079-2079
Open Access | Times Cited: 2
The Clinical Impact of Time-restricted Eating on Cancer: A Systematic Review
Eleah Stringer, Rob W G Cloke, Lindsay Van der Meer, et al.
Nutrition Reviews (2024)
Open Access | Times Cited: 2
Chronic Myeloid Leukemia following Exposure to Radioactive Iodine (I131): A Systematic Review
Yousef Hailan, Husam Al-Dubai, Mohamed A. Yassin
Oncology (2023) Vol. 101, Iss. 6, pp. 362-368
Open Access | Times Cited: 6
The effects of intermittent fasting on markers of health: A Narrative review
Maha Gasmi, Ruth Williams Hooker, Ghazwa ben Maaouia, et al.
Medical and Pharmaceutical Journal (2023), pp. 121-133
Open Access | Times Cited: 6
Intermittent fasting and its impact on toxicities, symptoms and quality of life in patients on active cancer treatment
Robert Li Sucholeiki, Casey L. Propst, David S. Hong, et al.
Cancer Treatment Reviews (2024) Vol. 126, pp. 102725-102725
Closed Access | Times Cited: 1
Avascular necrosis in patients with chronic myeloid leukemia: A systematic review.
Mohamed A. Yassin, Abdulrahman Al‐Mashdali, Husam Al-Dubai
PubMed (2022) Vol. 93, Iss. 1, pp. e2022017-e2022017
Closed Access | Times Cited: 5
Myasthenia Gravis and Myeloproliferative Neoplasms - Mere Association or Paraneoplastic Neurologic Syndrome: A Mini-Review.
Sreethish Sasi, Mouhand Mohamed, P. Chitrambika, et al.
PubMed (2022) Vol. 92, Iss. 6, pp. e2021437-e2021437
Closed Access | Times Cited: 4
Viral Infections and Incidence of Reactivations in Chronic Myeloid Leukemia Patients
Mahmood B Aldapt, Abdulrahman Al‐Mashdali, Khaldun Obeidat, et al.
Oncology (2023) Vol. 102, Iss. 4, pp. 380-388
Open Access | Times Cited: 2
Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials
Fateen Ata, Maria Benkhadra, Rola Ghasoub, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Dasatinib-Induced Colitis with Rectal Sparing in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy: Case Report
Zakaria Maat, Kamran Mushtaq, Mohamed A. Yassin
Case Reports in Oncology (2021) Vol. 14, Iss. 3, pp. 1441-1446
Open Access | Times Cited: 5
Radioactive Iodine-Induced Chronic Myeloid Leukemia in a Patient With Graves' Disease: A Case Report
Ahmed Yasin, Mohammad Abu‐Tineh, Awni Alshurafa, et al.
Cureus (2023)
Open Access | Times Cited: 1
Fasting Relationship with an Immune System and Heart Disease
Haylim N. Abud, Hiba S. Ahmed
Journal for Research in Applied Sciences and Biotechnology (2024) Vol. 2, Iss. 6, pp. 194-204
Open Access
Warm Autoimmune Hemolytic Anemia as First Presentation of Chronic Myeloid Leukemia: A Case Report
Ahmad Tawalbeh, Abdulrahman Al‐Mashdali, Ahmad Al‐Sabbagh, et al.
Case Reports in Oncology (2024) Vol. 17, Iss. 1, pp. 1351-1357
Open Access
Coexistence of Prefibrotic Myelofibrosis with Monoclonal Gammopathy of Undetermined Significance: A Case Report
Omar Ismail, Aliaa Amer, Feryal Ibrahim, et al.
Case Reports in Oncology (2021) Vol. 14, Iss. 3, pp. 1435-1440
Open Access | Times Cited: 2
Patient with clinical celiac disease mimicking triple‐negative essential thrombocythemia
Elrazi Ali, Kamran Mushtaq, Elabbass Abdelmahmuod, et al.
Clinical Case Reports (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 1
Osteolytic bone lesions in patients with primary myelofibrosis: A systematic review.
Naim Battukh, Elrazi Ali, Mohamed A. Yassin
PubMed (2022) Vol. 92, Iss. 6, pp. e2021478-e2021478
Closed Access | Times Cited: 1
Spontaneous tumor lysis syndrome in a patient with accelerated phase chronic myeloid leukemia treated successfully with rasburicase
Abdulrahman Al‐Mashdali, Mohamed A. Yassin
Medicine Case Reports and Study Protocols (2022) Vol. 3, Iss. 7, pp. e0244-e0244
Open Access
Page 1 - Next Page

Scroll to top